1 – 10 of 66
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Role of osteopontin and its regulation in pancreatic islet
- 2017
- Genomic correlates of glatiramer acetate adverse cardiovascular effects lead to a novel locus mediating coronary risk
- Predicting glycated hemoglobin levels in the non-diabetic general population : Development and validation of the DIRECTDETECT prediction model-a DIRECT study
- A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors
- Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance
- SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function
- New Blood Pressure-Associated Loci Identified in Meta-Analyses of 475 000 Individuals
- 2016
- Epigenetic regulation of glucose-stimulated osteopontin (OPN) expression in diabetic kidney.
- Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney.
- Glucose-Dependent Insulinotropic Polypeptide (GIP) Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB.